Sigyn Therapeutics, Inc. Annual Return On Equity in % from 2018 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Sigyn Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from 2018 to 2023.
  • Sigyn Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 106 %, a 24.6% decline year-over-year.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2023 was 134 %, a 36.4% decline from 2022.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2022 was 211 %.
  • Sigyn Therapeutics, Inc. annual Return On Equity for 2021 was -1.21K %, a 219% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 134 -76.8 -36.4% Jan 1, 2023 Dec 31, 2023
2022 211 +1.42K Jan 1, 2022 Dec 31, 2022
2021 -1.21K -2.23K -219% Jan 1, 2021 Dec 31, 2021
2020 1.02K +911 +841% Jan 1, 2020 Dec 31, 2020
2019 108 -57.2 -34.6% Jan 1, 2019 Dec 31, 2019
2018 165 Jan 1, 2018 Dec 31, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.